These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


578 related items for PubMed ID: 36215790

  • 1. Danshen injection induces autophagy in podocytes to alleviate nephrotic syndrome via the PI3K/AKT/mTOR pathway.
    Chen J, Yuan S, Zhou J, Huang X, Wu W, Cao Y, Liu H, Hu Q, Li X, Guan X, Yin S, Jiang J, Zhou Y, Zhou J.
    Phytomedicine; 2022 Dec; 107():154477. PubMed ID: 36215790
    [Abstract] [Full Text] [Related]

  • 2. Qizhi Jiangtang capsule activates podocyte autophagy in diabetic kidney disease by inhibiting phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin pathways.
    Zhaoan G, Lina S, Yingying L, Ruifeng LI, Chong L, Ke D, Jing S, Jun S.
    J Tradit Chin Med; 2023 Aug; 43(4):667-675. PubMed ID: 37454251
    [Abstract] [Full Text] [Related]

  • 3. Ameliorative effects of Modified Huangqi Chifeng decoction on podocyte injury via autophagy mediated by PI3K/AKT/mTOR and AMPK/mTOR pathways.
    Zhao M, Yin Y, Yang B, Chang M, Ma S, Shi X, Li Q, Li P, Zhang Y.
    J Ethnopharmacol; 2024 Mar 01; 321():117520. PubMed ID: 38042389
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of Gubenyiliu formula II and its disassembled prescriptions on cell autophagy in breast cancer through PI3K/AKT/mTOR pathway.
    Chen X, Jin G, Luo H, Zhou L.
    Anticancer Drugs; 2023 Jul 01; 34(6):725-734. PubMed ID: 36727774
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Spironolactone promotes autophagy via inhibiting PI3K/AKT/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress.
    Li D, Lu Z, Xu Z, Ji J, Zheng Z, Lin S, Yan T.
    Biosci Rep; 2016 Aug 01; 36(4):. PubMed ID: 27129295
    [Abstract] [Full Text] [Related]

  • 11. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
    Yang F, Qu Q, Zhao C, Liu X, Yang P, Li Z, Han L, Shi X.
    Biomed Pharmacother; 2020 Sep 01; 129():110479. PubMed ID: 32768963
    [Abstract] [Full Text] [Related]

  • 12. Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cells.
    Wang KF, Yang H, Jiang WQ, Li S, Cai YC.
    Int J Mol Med; 2015 Dec 01; 36(6):1556-62. PubMed ID: 26499488
    [Abstract] [Full Text] [Related]

  • 13. Salvianolic acid B attenuates membranous nephropathy by activating renal autophagy via microRNA-145-5p/phosphatidylinositol 3-kinase/AKT pathway.
    Chen J, Hu Q, Luo Y, Luo L, Lin H, Chen D, Xu Y, Liu B, He Y, Liang C, Liu Y, Zhou J, Wu J.
    Bioengineered; 2022 May 01; 13(5):13956-13969. PubMed ID: 35723058
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K/AKT/mTOR pathway.
    Chiou TT, Chau YY, Chen JB, Hsu HH, Hung SP, Lee WC.
    Biomed Pharmacother; 2021 Dec 01; 144():112349. PubMed ID: 34700229
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Leptin relieves ischemia/reperfusion induced acute kidney injury through inhibiting apoptosis and autophagy.
    Li S, Zhuang K, He Y, Deng Y, Xi J, Chen J.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jan 28; 47(1):8-17. PubMed ID: 35545358
    [Abstract] [Full Text] [Related]

  • 19. Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway.
    Jin D, Liu F, Yu M, Zhao Y, Yan G, Xue J, Sun Y, Zhao D, Li X, Qi W, Wang X.
    J Ethnopharmacol; 2022 Jul 15; 293():115246. PubMed ID: 35398500
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.